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Abstract
Like other CNS neurons, mature retinal ganglion cells (RGCs) are unable to regenerate their axons after nerve injury due to a
diminished intrinsic regenerative capacity. One of the reasons why they lose the capacity for axon regeneration seems to be
associated with a dramatic shift in RGCs’ program of gene expression by epigenetic modulation. We recently reported that
(1R)-isoPropyloxygenipin (IPRG001), a genipin derivative, has both neuroprotective and neurite outgrowth activities in
murine RGC-5 retinal precursor cells. These effects were both mediated by nitric oxide (NO)/S-nitrosylation signaling.
Neuritogenic activity was mediated by S-nitrosylation of histone deacetylase-2 (HDAC2), which subsequently induced
retinoic acid receptor b (RARb) expression via chromatin remodeling in vitro. RARb plays important roles of neural growth
and differentiation in development. However, the role of RARb expression during adult rat optic nerve regeneration is not
clear. In the present study, we extended this hypothesis to examine optic nerve regeneration by IPRG001 in adult rat RGCs
in vivo. We found a correlation between RARb expression and neurite outgrowth with age in the developing rat retina.
Moreover, we found that IPRG001 significantly induced RARb expression in adult rat RGCs through the S-nitrosylation of
HDAC2 processing mechanism. Concomitant with RARb expression, adult rat RGCs displayed a regenerative capacity for
optic axons in vivo by IPRG001 treatment. These neuritogenic effects of IPRG001 were specifically suppressed by siRNA for
RARb. Thus, the dual neuroprotective and neuritogenic actions of genipin via S-nitrosylation might offer a powerful
therapeutic tool for the treatment of RGC degenerative disorders.
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Introduction
In contrast to the PNS, neurons of the adult CNS do not
normally display axon regeneration after nerve injury. The
neonatal nervous system of mammals retains some capacity for
CNS regeneration but lose this ability after birth [1]. In newborn
stages, RGCs can regrow injured axon within 1–2 weeks after
birth [2], [3]. This switch of capacity for axon regeneration is
associated with a dramatic shift in RGCs’ program of gene
expression [4]. The normal development induces restrictive
expression of growth associated genes [5] and regeneration
associated genes [6]. One of cell-intrinsic change that may
contribute to RGCs’ loss of regenerative potential is a decrease
of histone acetylation. Histone acetylation declines in rat RGCs
within 2–3 weeks after birth and decreases even further after nerve
injury [7]. Thus, we hypothesize that re-expression of regeneration
associated genes which show highly expression in neonatal but not
in adulthood in RGCs are able to regenerate optic nerve after
injury.
Genipin, an herbal iridoid, has been shown to have both
neuroprotective and neuritogenic activity in PC12h cells and
Neuro2a cells [8–12]. Recently, we extended this activity to RGC-
5, retinal precursor cell line using (1R)-isoropyloxygenipin
(IPRG001), a long-acting genipin derivative. IPRG001 showed
significant neuroprotective activity in RGC-5 cells against
oxidative stress, such as hydrogen peroxide exposure [13].
Furthermore, IPRG001 sufficiently promoted staurosporine-in-
duced neurite outgrowth from RGC-5 cells in a dose-dependent
manner [14]. However, whether IPRG001 can be used to enhance
axon regeneration after injury in vivo has not been shown. The
molecular mechanism of genipin-induced neuroprotective and
neurite outgrowth activity was initially believed to be neural nitric
oxide synthase (nNOS)/nitric oxide (NO) -dependent because of
its structural similarity to tetrahydrobiopterin, which is a cofactor
for NOS enzymatic activity [15]. Indeed, both the neuroprotective
and neuritogenic effects of IPRG001 in RGC-5 cells were all
nNOS/NO-dependent [13,14]. As protein S-nitrosylation is a
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sequential event following NO generation by nNOS activation, we
focused on this modification in RGC-5 cells because of the
ineffectiveness of NO/cGMP signaling [14]. However, the target
proteins of S-nitrosylation for neuroprotection and neurite
outgrowth were different for each activity. The neuroprotective
target is Kelch-like ECH-associated protein-1 (Keap1)/NF-E2
related factor2 (Nrf2), leading to the activation of antioxidative
protein expression, whereas the neuritogenic target on the RGC-5
cells is histone deacetylase 2 (HDAC-2), leading to the induction of
histone acetylation and retinoic acid receptor b (RARb) expression
[13], [14]. Retinoic acid signaling plays essential roles in neural
development, growth, and cellular differentiation [16] via mem-
bers of the nuclear receptor family including RARs. Especially, the
expression levels of RARb are restricted in adult retina [17].
However, the role of RARb upon adult rat optic nerve
regeneration is unknown. Therefore, in the present study, we
examined the neuritogenic properties of genipin on optic nerve
regeneration in adult rat retinal ganglion cells (RGCs) in vivo after
nerve injury. IPRG001 induced RARb expression in adult rat
RGCs through the NO/S-nitrosylation pathway. Concomitant
with RARb expression, IPRG001 successfully regenerated optic
axons from matured rat RGCs in vivo. These findings may be




All animal care and handling procedures were approved by the
Animal Care and Use Committee of Kanazawa University
(No.111848). All surgery was performed under sodium pentobar-
bital anesthesia, and all efforts were made to minimize suffering.
Chemicals
Genipin was purchased from Wako Pure Chemical Industries,
Ltd. (Osaka, Japan). (1R)-isoPropyloxygenipin (IPRG001) was
synthesized from genipin, as previously described [18], and
dissolved in dimethylsulfoxide. 2-(4-carboxyphenyl)-4, 4, 5, 5-
tetramethylimidazoline-1-oxyl-3-oxide sodium salt (c-PTIO) and
S-ethyl-N-[4-(trifluoromethyl) phenyl] isothiourea (ETPI), were
obtained from Alexis Co. (San Diego, CA, USA).
Animals and Surgery
Sprague–Dawley male rats (postnatal 1 day to adult (body
weight, 250–300 g)) were used throughout this study. Rats were by
intraperitoneal injection of sodium pentobarbital (30–40 mg/kg
body weight). Intravitreal injections of various reagents were
performed with a Hamilton microsyringe (Hamilton Syringe,
Whitteier, CA, USA) 30G needle. Injections were performed by
the sclera and retina with a needle 1–2 mm superior to the optic
nerve head to avoid lens injury which itself leads to considerable
regeneration as a consequence of one or more trophic factors
associated with inflammatory cells [19]. As the control of each
experiment, we injected vehicles to eye ball. The volume of
injection was set at 5 ml of total volume after pre-suction of the
same volume of vitreal fluid. After lateral canthotomy of rats, the
conjunctiva was incised laterally to the cornea, the retractor bulbi
muscle was separated, and the optic nerve exposed under the
binocular-operating microscope. Optic nerve was crushed 2 mm
behind the eye with angled jeweler’s forceps (Dumont # 5) for
10 sec, avoiding injury to the ophthalmic artery as previously
described [20]. Rats were housed in clear plastic cages and
maintained under the 12 h light/dark cycles at 23uC.
Retinal Explant Culture
Rat retinal explant cultures were performed as previously
described [14]. Retinas were cut into small pieces (0.5 mm
squares) and cultured in medium containing DMEM (Sigma-
Aldrich, St Louis, MO, USA), 10% fetal bovine serum and
penicillin–streptomycin (100 mg/ml–100 U/ml, respectively) in
collagen gel (Cellmatrix; Nitta Gelatin, Osaka, Japan) on a
35 mm culture dish. We observed neurite outgrowth in each
explant from total 30–40 explants per dish using phase contrast
microscopy. Positive neurite outgrowth was defined on the basis of
the length (.200 mm) of the neurites, following the description in
our previous study [14]. We showed the percentage of explants
with positive neurites. Four independent experiments were
repeated.
Immunohistochemistry
Tissue fixation and cryosectioning were performed as previously
described [21]. Briefly, the eyes and optic nerves were isolated and
fixed in 4% paraformaldehyde containing 0.1 M phosphate buffer
(pH 7.4) and 5% sucrose for 2 h at 4uC. Sucrose concentration
was gradually increased from 5 to 20%. The eyes were then
embedded in optimal cutting temperature compound, Tissue Tek
(Sakura Finetek, Tokyo Japan) and cryosectioned at 12 mm
thickness. The frozen sections were mounted and blocked with
Blocking One (Nacalai Tesque, Japan) and retinal sections were
incubated with primary anti-nNOS (1:500), anti-RARb (1:500)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-NeuN
(1:500, Millipore, Billerica, MA, USA) and anti-acetyl histone H3
(1:500, Cell Signaling Technology, Tokyo, Japan) antibodies. The
sections were then incubated with Alexafluoro anti-IgG (Molec-
ular probe, Eugene, OR, USA).
NADPH Diaphorase Staining
Tissue fixation and cryosectioning were performed as previously
described [22]. The frozen sections were mounted onto silane-
coated glass slides and air-dried. The slides were then brought to
23uC and incubated overnight in 0.1 M Tris-HCl (pH 8.0)
containing 0.3% Triton-X 100. Each sample was stained in buffer
containing NADPH and 4-nitroblue tetrazolium chloride (Roche
Diagnostics Corporation, Indianapolis, IN, USA) for 2–3 h at
37uC.
Subcellular Fractions for the Extraction of RARb Protein
Retinas were lysed in hypotonic buffer containing 10 mM
HEPES-KOH (pH7.9), 10 mM KCl, 1.5 mM MgCl2, 1 mM
DTT, 0.5 mM phenylmethylsulfonyl fluoride, protease inhibitor
cocktail and centrifuged at 10,000 g for 15 min at 4uC. The
supernatants were used as the cytoplasmic fraction and the pellets
were incubated with a nuclear lysis buffer containing 20 mM
HEPES-KOH (pH7.9), 400 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 5% glycerol, and protease inhibitor cocktail
(Sigma-Aldrich) for 30 min on ice. The lysates were centrifuged at
18,000 g for 15 min at 4uC. The supernatants contained the
nuclear fraction. Immunoblotting analysis of b-actin and histone
H4 was performed to ensure no contamination of cytoplasmic and
nuclear fractions.
Western Blot Analysis
Retinal explants or retinas from various conditions were
extracted and 30 mg of protein were subjected to polyacrylamide
gel electrophoresis using a 5–20% gradient gel as previously
described [22]. The separated proteins were transferred to a
nitrocellulose membrane and incubated with primary and
IPRG001 Induces ON Regeneration via RARb Induction
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e71252
secondary antibodies (Santa Cruz Biotechnology). Protein bands
(nNOS (1:500), RARb (1:500)) were detected using a BCIP/NBT
Kit (Funakoshi, Tokyo, Japan). Antibodies against b-actin (1:500,
Gene Tex, San Antonio, TX) and histone H4 (1:500, Cell
Signaling Technology, Tokyo, Japan) were used as an internal
standard. Protein bands isolated from cells cultured under various
conditions were analyzed densitometrically using Scion Image
Software (Scion Corp. Frederick, MD, USA). All experiments
were repeated at least three times.
S-Nitrosylation Analyses of HDAC2
S-Nitrosylation of HDAC2 was assessed by a modified of biotin
switch assay [23] using the S-nitrosylated Protein Detection Assay
Kit (Cayman Chemical, Ann Arbor, MI). Retinas exposed to
agents for 1 day were harvested and lysed at 4uC. Free thiols were
blocked by adding S-methyl methanethiosulfonate and biotinyla-
tion of nitrosothiols was performed using maleimide-biotin.
Biotinylated proteins were further purified by overnight incubation
with neutravidin-coupled agarose beads (Pierce-Thermo Scientific,
Rockford, IL, USA). After incubation, beads were washed three
times with PBS. Isolated proteins were recovered from beads by
the addition of Laemmli sample buffer, and heated at 85uC for
10 min. The amount of S-nitrosylated HDAC2 protein in the
samples was analyzed by western blot analysis using anti-HDAC2
antibody (1:500, Cell Signaling Technology, Tokyo, Japan).
Application of siRNA for RARb
Small interfering RNA (siRNA) for the target region of RARb
mRNA were as follows: 59-GGAGCCGACUGCAAAUACAAG-
39 (sense); 59-UGUAUUUGCAGUCGGCUCCAA-39 (antisense)
(Sigma-Aldrich, Japan); and a randomly shuffled sequence: 59-
AGUCGUCGUAUACGGUAUAUC -39 (sense); 59-UAUACC-
GUAUACGACGACUUC -39 (antisense). In retinal explant
culture, transfection of siRNA (100 pmol) into retinal explants
was carried out using Lipofectamine 2000 (Invitrogen Corpora-
tion, Carlsbad, CA, USA) for 4 h before culture. In rat retina,
knockdown of RARb expression was performed by injecting
siRNA (2 mg) using a 30-gauge syringe to eyes as described [24],
[25]. After injection, five square 80 V pulses of 50 ms duration
with 950 ms intervals were applied by NEPA21 (Nepagene,
Chiba, Japan) with forcep-type electrodes. After 5 days of
electroporation, retinal cells were cultured, and optic nerves were
crushed.
Quantitation of Optic Nerve Regeneration in vivo
Rats were sacrificed at 14 days after optic nerve injury and were
perfused with 4% paraformaldehyde. Optic nerves were impreg-
nated with 5% and then 30% sucrose, embedded in Optimal
Cutting Temperature compound (Sakura Finetechnical, Tokyo,
Japan) and cut into longitudinal sections of 14 mm thickness.
Regenerating optic axons were visualized by staining with mouse
anti-GAP43 antibody (1:250, Santa Cruz Biotechnology, Santa
Cruz, CA) followed by a fluorescently-labeled secondary antibody
and captured by fluorescent microscopy (BZ-9000, Keyence,
Osaka, Japan). Axons were counted manually in at least 8 sections
per conditions (6 rats of each treatment) at prespecified distances
(250 mm and 500 mm) away from the injury site. The numbers of
regenerating axons were counted as described by Leon et al. [19].
Counting of Surviving RGCs
RGC survival was evaluated in flat-mounted retinas by
immunohistochemistry using a mouse antibody against bIII-
tubulin (TUJ1, R&D Systems, Inc., Minneapolis, USA 1:500),
followed by a fluorescent secondary antibody after 10 days of
injury. Images of 8 prespecified retinal areas of 3 mm away from
the optic disc (middle region of the retina) were captured by
fluorescent microscopy (under x200 magnification; E600, Nikon)
and positive cells were counted using ImageJ software (Wayne
Rasband, NIH, Bethesda, MD). Cell densities were calculated as
mean values of surviving RGCs per 0.14 mm2 in the 8 specified
areas. Data are presented as means 6 S.E.M on five rats per
group.
Statistics
All results were reported as mean 6 SEM for 3–5 experiments.
Differences between groups were analyzed using one-way
ANOVA, followed by Dunnett’s multi-comparison test with
PASW Software (SPSS Inc., Chicago, IL, USA). P values ,0.05
were considered statistically significant.
Result
Correlation between Axonal Regeneration and RARb
Expression in the Developing Rat Retina
Newborn rat retina at postnatal day 1 (P1) showed spontaneous
axonal regeneration in explant cultures forming long neurites
more than 200 mm in length (Fig. 1A). In contrast, rat retina at
postnatal day 14 (P14, Fig. 1B), and day 60 (P60, Fig. 1C) lost the
capacity for axonal regeneration in explant culture. Figure 1D
shows a graphical representation of neurite outgrowth in P1, P14
and P60 rat retinal explant cultures. In P14 rat retina, neurite
outgrowth was about 30% of P1 retina. In P60 rat retina, neurite
outgrowth was less than 10% of P1 retina. To ascertain the levels
of retinoic acid receptor b (RARb) in rat retina after birth, we
performed western blot analysis in the total retina at P1, P5, P14
and P60. Figure 1E shows a graphical representation of RARb
protein expression in developing rat retinas. In P5 rat retina, the
levels of RARb expression were 68% of P1 rat. In P14 rat retina,
the level of RARb expression was about 30% of P1 rat. In P60 rat
retina, the expression was less than 30% of P1 rat. Histone H4
protein did not change during this period (Fig. 1E). Similarly, we
performed immunohistochemistry for RARb protein expression in
the developing rat retina. At P1 rat retina, strong immunoreac-
tivity for RARb could be seen in the retinal ganglion cell layer
(Fig. 1F). The localization of RARb in RGCs was further
confirmed using anti-NeuN, a potent marker of RGCs [26], [27]
(Fig. 1G and Fig. 1H merged). In P14 rat retina, RARb expression
in the RGCs was decreased compared to P1 rat retina (Figs. 1 I, J,
K). In adult P60 rat retina, RARb expression in the RGCs was
barely visible (Figs. 1 L, M, N). From these results similarity
between neurite outgrowth and RARb expression in development
retina, we next examined the effect of RARb knockdown with
retinal explant culture on neurite outgrowth. A specific siRNA for
RARb suppressed the neurite outgrowth to 63% (RARb
expression to 52%) compared with no treated control of P1 retina
(Figs. 1P and Q), whereas scrambled RNA did not suppress both
neurite outgrowth and RARb expression (Fig. 1O and Q).
Increased NOS Activity and nNOS Expression in rat RGCs
by IPRG001 Treatment
As we showed that IPRG001 induced neurite outgrowth in
RGC-5 cells through nNOS/NO signaling [14], we examined
NOS activity and nNOS expression in the rat retina after
intraocular injection of IPRG001. To examine NOS activity, we
studied histochemical staining of NADPH diaphorase activity,
which was associated with NOS activity [22], [28]. Intraocular
injection of IPRG001 (100 pmol/eye) significantly increased
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NADPH diaphorase staining in RGCs (Fig. 2B) 1 day after
treatment compared to vehicle control retina (Fig. 2A). Next, we
studied the effects of IPRG001 on nNOS protein expression in the
adult rat retina by western blot. Intraocular IPRG001 significantly
increased nNOS protein levels 2.5-fold at 1 day after treatment
compared to vehicle control (Fig. 2C). The increase in nNOS
expression returned to control levels by 5 days after treatment.
Levels of b-actin expression did not change during this period
(Fig. 2C). We further compared nNOS expression with or without
IPRG001 injection at 1 day following optic nerve injury (Fig. 2D).
Optic nerve injury did not change the levels of nNOS expression
at this period compared to control as reported by Lee et al. [29].
IPRG001 increased a similar level of nNOS protein at 1 day after
treatment with or without optic nerve injury. To determine nNOS
protein expression by IPRG001, we performed double-staining in
adult rat retina with anti-nNOS and anti-NeuN antibodies. At 1
day after IPRG001 treatment, a strong immunoreactivity for
nNOS could be seen in RGCs (Figs. 2F, H, J) compared to the
control retina (Figs. 2E, G, I). The localization of increased
Figure 1. Correlation between axon outgrowth and RARb expression in rat retina after birth. (A) P1 retinal explant, (B) P14 retinal explant,
(C) P60 retinal explant, Scale = 100 mm. (D) Quantification of axon outgrowth from rat retinal explants at various days after birth. Y axis shows % of
explants with neurites longer than 200 mm. *P,0.01 vs P1 retina. (n = 3, 5 rats of each stage). (E) Quantification of RARb expression in rat retina during
development. *P,0.05, **P,0.01 vs P1 (n = 3). (F–N) RARb and NeuN expression in the rat retina during development. (F, I, L) RARb expression at P1
(F), P14 (I) and P60 (L). Scale = 50 mm. (G, J, M) NeuN-positive RGCs at P1 (G), P14 (J), and P60 (M). (H, K, N) Merged images of each day at P1 (H), P14
(K), and P60 (N). (O) P1 retina treated with scrambled siRNA (P) siRNA for RARb in P1. Scale = 100 mm. (Q) siRNA of RARb suppressed expression of
RARb and neurite outgrowth in P1 retina. *P,0.01 vs vehicle control (Con) and scrambled siRNA(Scr) (RARb expression), +P,0.01 vs Con and Scr
(neurite outgrowth), (n = 3, 5 rats of each treatment).
doi:10.1371/journal.pone.0071252.g001
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expression of nNOS by IPRG001 was also observed in RGCs after
nerve injury (data not shown).
Increased RARb Expression in Adult Rat RGCs with
IPRG001 Treatment through nNOS/NO Signaling
In our previous study, we found that IPRG001 induced RARb
expression through nNOS/NO signaling in RGC-5 cells [14]. In
this study, we investigated the effects of IPRG001 on RARb
expression in the adult rat retina. The changes of RARb protein
expression in the rat retina were examined for 5 days after
treatment (Fig. 3A). RARb rapidly increased by 3-fold of control
levels in the retina at 1 day and gradually declined to lower levels
by day 5 post-treatment (Fig. 3A). Histone H4 expression did not
change during this period. IPRG001 induced a similar level of
RARb protein at 1 day after treatment with or without optic nerve
injury (Fig. 3B). Next, we performed immunohistochemistry for
RARb protein expression in the rat retina after treatment of
IPRG001. In vehicle control retina, weak RARb expression was
seen in RGCs with anti-RARb and anti-NeuN antibodies
(Figs. 3C, D, E). Intraocular IPRG001 (100 pmol/eye) increased
RARb expression in RGCs at 1 day post-treatment (Figs. 3F, G,
H). The localization of RARb expression by IPRG001 was seen in
RGCs at 1 day after nerve injury (data not shown). The induction
of RARb expression by IPRG001 in the rat retina was significantly
blocked by a NO scavenger, c-PTIO (500 pmol) or a specific
nNOS inhibitor, ETPI (200 pmol) (Fig. 3I). Neither c-PTIO nor
ETPI had any effects on RARb expression in vehicle control
retina. These data strongly indicate that the IPRG001-induced
RARb expression in the adult rat RGCs was nNOS/NO-
dependent.
IPRG001-induced S-nitrosylation of Histone Deacetylase
2 (HDAC2) and Acetylation of Histone H3
In our previous study, we showed that IPRG001-induced
nNOS/NO signaling occurred after the S-nitrosylation of HDAC2
leading to increased RARb expression and neuritogenesis in
RGC-5 cells [14]. Therefore, we investigated the S-nitrosylation of
HDAC2 after IPRG001 treatment. Figure 4A shows a 2.6-fold
increase in the S-nitrosylation of HDAC2 at 1 day after IPRG001
(100 pmol/eye) treatment. The S-nitrosylation of HDAC2 was
also nNOS/NO-dependent. c-PTIO or ETPI significantly blocked
HDAC2 S-nitrosylation (Fig. 4A). Figure 4B illustrates a graphical
representation of acetylated histone H3 (AcH3) with IPRG001
(100 pmol/eye) treatment. IPRG001 increased AcH3 2.3-fold in
the rat retina at 1 day and returned to control levels by 5 days post
treatment. The increase of AcH3 by intraocular IPRG001 was
Figure 2. IPRG001 activates NADPHd staining and nNOS protein expression in the rat retina. (A, B) NADPHd staining in the retina
increased at 1 day post-treatment with 100 pmol/eye of IPRG001 (B) as compared to vehicle control (A). Scale = 100 mm. (C) Western blot analysis of
nNOS protein after treatment of IPRG001. *P,0.01 vs control (n = 3). (D) Levels of nNOS expression by IPRG001 with or without optic nerve injury.
*P,0.01 vs control (n = 3). (E–J) nNOS and NeuN expression in the retina after treatment of IPRG001. (E and F) Immunoreactivity of nNOS protein was
increased in RGCs at 1 day after IPRG001 treatment (F) compared to vehicle control (E). Scale = 50 mm. (G and H) NeuN staining of E and F. (I and J)
Merged images.
doi:10.1371/journal.pone.0071252.g002
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almost blocked by ETPI (Fig. 4C). Immunohistochemical staining
revealed that IPRG001 significantly enhanced immunoreactivity
of AcH3 in rat RGCs at 1 day after treatment (Figs. 4 G, H, I)
compared to vehicle control retina (Figs. 4D, E, F). The data
indicate that there is a good correlation between the S-
nitrosylation of HDAC2 and AcH3 in the rat retina for 1day
treatment of IPRG001.
Figure 3. Upregulation of RARb expression in RGCs after IPRG001 treatment. (A) Western blot analysis of RARb protein expression
increased at 1 day after treatment of IPRG001. *P,0.01 vs control (n = 3). (B) Levels of RARb expression by IPRG001 with or without optic nerve injury.
*P,0.01 vs control (n = 3). (C–H) RARb and NeuN expression in the retina after treatment of IPRG001. (C and F) Immunoreactivity of RARb protein was
increased in RGCs 1 day after treatment with IPRG001 (F) compared to vehicle control (C). Scale = 50 mm. (D and G) NeuN staining of C and F. (E and
H) Merged images. (I) nNOS/NO-dependent expression of RARb by IPRG001. *P,0.05, **P,0.01 vs control, +P,0.01 vs IPRG001 treatment alone
(n = 3).
doi:10.1371/journal.pone.0071252.g003
IPRG001 Induces ON Regeneration via RARb Induction
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e71252
Intraocular IPRG001 Promotes Optic Nerve Regeneration
from Adult Rat RGCs through a RARb-dependent
Mechanism after Nerve Injury
As IPRG001 enhanced neurite outgrowth from retinal explants
in vitro [14], we further confirmed this activity in vivo preparation
after nerve injury. Intraocular IPRG001 (100 pmol/eye) induced
optic nerve regeneration in vivo (Fig. 5C) compared to vehicle
control (Fig. 5A), which was revealed by GAP43 staining. siRNA
for RARb significantly suppressed the effects of IPRG001 (Fig. 5E).
c-PTIO also attenuated the IPRG001-induced optic nerve
regeneration (Fig. 5G) although c-PTIO alone did not change
the optic nerve regeneration of no treatment (data not shown).
Figures 5B, D, F, H show enlarged images of the areas enclosed
within the white boxes in Figs. 5A, C, E, G, respectively. IPRG001
(Fig. 5D) showed many regenerating fibers compared to control
(Fig. 5B), IPRG001 plus siRNA (Fig. 5F), or IPRG001 plus c-
PTIO (Fig. 5H). Figure 5I illustrates the quantitative data of optic
nerve regeneration in vivo at 250 mm and 500 mm away from the
Figure 4. S-Nitrosylation of HDAC2 and the acetylation of histone H3 in the rat retina by IPRG001. (A) S-Nitrosylation of HDAC2 1 day
after intraocular administration of IPRG001. NO scavenger, c-PTIO or nNOS inhibitor, ETPI was treated 1 h before IPRG001 treatment. Biotinylated
proteins were mixed with avidin beads, eluted and analyzed by western blotting with anti-HDAC2 antibody. **P,0.01 vs control. +P,0.01 vs IPRG001
treatment alone (n = 3). (B) Levels of acetylated histone H3 (AcH3) after treatment of IPRG001. *P,0.05, **P,0.01 vs control (n = 3). (C) nNOS
dependent histone H3 acetylation by IPRG001. ETPI was treated 1 h before IPRG001. *P,0.01 vs control. +P,0.01 vs IPRG001 treatment alone (n = 3).
(D–I) Immunohistochemistry of AcH3 and NeuN in rat RGCs. Levels of AcH3 were increased 1 day after IPRG001 treatment (G–I) compared to vehicle
control (D–F). (D and G) Immunoreactivity of AcH3. (E and H) NeuN staining. (F and I) Merged images. Scale = 20 mm.
doi:10.1371/journal.pone.0071252.g004
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crush site of optic nerve (asterisk). At both sites, siRNA for RARb
significantly cancelled the effects of IPRG001. In contrast,
scramble siRNA did not affect the axon elongation effects of
IPRG001. siRNA and scramble siRNA alone did not affect the
basal level of optic nerve regeneration without IPRG001
treatment (Fig. 5I).
RARb Induction by IPRG001 did not Promote RGCs
Survival after Nerve Injury
IPRG001 sufficiently rescued rat RGCs against optic nerve
injury through antioxidative mechanism [13]. Here, we further
examined whether or not the protective effect of IPRG001 was
mediated through a RARb expression mechanism. We therefore
counted the number of surviving RGCs by staining of anti-TUJI
antibody after nerve injury. Optic nerve injury drastically reduced
the number of surviving RGCs at 10 days after nerve injury
(Fig. 6B) as compared to the vehicle control (Fig. 6A). IPRG001
certainly rescued the RGCs cell death after injury (Fig. 6C).
However, neither siRNA for RARb (Fig. 6D) nor scrambled
siRNA affects this protection of RGCs cell death by IPRG001
(Fig. 6E). Fig. 6E illustrates a graphical representation of the
number of surviving RGCs after optic nerve injury with or without
siRNA for RARb. These results suggest that this RARb induction
by IPRG001 is targeted only to the neuritogenic action, not to
survival action.
Discussion
A Correlation between Neurite Outgrowth and RARb
Expression in the Developing Rat Retina
Immature retina has a higher capacity for optic nerve
regeneration rather than mature retina in vitro [30]. However,
the rat retina gradually loses this capacity for regeneration with
development, although the reason remains unsolved. Goldberg
et al. [3] reported that rat retinal ganglion cells (RGCs) of
embryonic day 20 (E20) had the most intensive capacity for
extending optic axons and they showed a higher extension of optic
axons 7-fold than the RGCs at postnatal day 8 (P8). We confirmed
these results with developing rat retinas of postnatal days 1, 14 and
60 (Fig. 1). It is also known that retinoic acid (RA) signaling is
involved in neural development and regeneration regulated
through nuclear RA receptors (RARs). In the dorsal root ganglia
and spinal cord, a particular role of RARb expression was
implicated in nerve regeneration after nerve injury. Grondona
et al. [31] reported that RARb expression in the mouse retina
could be seen in RGCs from postnatal days 0 to 21 (P0–P21). Mori
et al. [32] also reported RARb expression in the developing rat
retina. RARb expression in P14 or P60 rat RGCs was less than
Figure 5. IPRG001-induced rat optic nerve regeneration under
RARb-dependent conditions in vivo. (A, C, E, G) Longitudinal
sections of the adult rat optic nerve showing GAP-43 positive axons
extending over the injury site (asterisks) after 2 weeks after optic nerve
injury. (B, D, F, H) Enlarged image of the area enclosed within the white
box of A, C, E, G. Scale = 50 mm. (A) Vehicle control, Scale = 250 mm. (C)
IPRG001, (E) IPRG001 plus siRNA for RARb. (G) IPRG001 plus c-PTIO
(500 pmol). (I) Quantification of axonal regrowth at two indicated
proximal points from the injury site (250 mm and 500 mm). **P,0.01 vs
control, +P,0.01 vs injury plus IPRG001 (n = 8, 6 rats per each group).
doi:10.1371/journal.pone.0071252.g005
Figure 6. No effect of RARb expression on RGCs survival
induced by IPRG001. (A-D) Surviving RGCs stained by TUJ1 in whole
mount retina. (A) Vehicle control. Scale = 50 mm. (B) 10 days after injury.
(C) Injury plus IPRG001. (D) Injury plus IPRG001 with RARb-specific
siRNA. (E) Quantification of surviving RGCs after nerve injury with or
without siRNA for RARb. *P,0.01 vs control, +P,0.01 vs injury (n = 8).
doi:10.1371/journal.pone.0071252.g006
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30% of those at P1 (Fig. 1E). The cellular localization of RARb in
RGCs was confirmed by double-staining of NeuN labeling [26].
This time course of RARb expression in the developing rat retina
was very comparable to that of our data (cf. Fig. 1D and Fig. 1E).
Furthermore, we indicated that specific siRNA for RARb
significantly suppressed neurite outgrowth in P1 retina. These
results suggest that RARb is one of the important molecules for
neuritogenesis in developing retina. The data of developing rat
retina further encouraged us to investigate the neuritogenic
activity of RARb in adult rat retina in vivo.
RARb Expression Induced by IPRG001 is Mediated via
NO/S-nitrosylation of HDAC2
In the previous study with RGC-5 cells, IPRG001 promoted
staurosporine-induced neurite outgrowth in an nNOS/NO-
dependent manner [14]. RGC-5 cells were treated with staur-
osporine to arrest cell growth and induce cell differentiation [33].
RGC-5 cells are known as neuronal precursor cells of retinal
origin. Recently, Van Bergen et al. [34] reported the re-
characterization of RGC-5 cells. Differentiated by staurosporine,
RGC-5 cells express the RGCs markers, Thy1 and the NMDA
receptor [35,36]. Thus, we used staurosporine as a reagent for
RGC-5 differentiation as an in vitro model of RGCs. However,
whether IPRG001 can be used to enhance axon regeneration of
RGCs after injury in vivo has not been shown. The neurite
outgrowth activity of IPRG001 in RGC-5 cells is mediated by the
S-nitrosylation of HDAC2. It is well known that the inhibition of
HDAC2 induces chromatin remodeling that leads to the
transcriptional activation of genes including RARb [37–39]. Nott
et al. [40] further reported that the S-nitrosylation of HDAC2 also
caused chromatin remodeling in the neural cells like HDAC2
inhibition. In our examination of RGC-5 cells in vitro, the
induction of RARb by IPRG001 was nNOS/NO- and HDAC2
S-nitrosylation-dependent [14]. In the present study, IPRG001
significantly S-nitrosylated HDAC2 in rat RGCs at 1 day post
treatment. The HDAC2 S-nitrosylation in the rat retina was also
nNOS/NO-dependent. A NO scavenger and nNOS inhibitor
clearly suppressed RARb expression. HDAC inhibitor, which can
induce histone H3 acetylation (AcH3) and RARb expression [38],
dramatically promotes neurite outgrowth in retinal explant culture
[41]. Moreover, it has reported that HDAC inhibitor, trichostatin
A strongly induced histone H3 acetylation, neuritogenesis in
RGCs [7], [42] and RARb expression [43], [44]. Our data of
IPRG001 well agree with their results. IPRG001 increased AcH3
in the rat RGC 2.6-fold at 1 day after optic nerve injury by
western blot analysis (Fig. 4C). This increase of AcH3 was nNOS-
dependent. ETPI, a nNOS inhibitor completely blocked the
IPRG001-induced increase of AcH3. These data strongly indicate
that IPRG001 leads chromatin remodeling like an HDAC2
inhibitor through an NO/S-nitrosylation mechanism. Recently,
Gaub et al. [7] reported that the levels of histone acetyltransferase
P300 protein and histone acetylation (AcH3) in the rat RGCs
decreased with maturation. This property might be one of the
reasons why mammalian optic nerves lost the capacity for optic
nerve regeneration after nerve injury [41].
Role of RARb Expression in Rat RGCs for Optic Nerve
Regeneration
In general, successful CNS regeneration after nerve injury is
mainly dependent on neuritogenesis. As for neuronal cell survival,
the overexpression of Bcl-2, an antiapoptotic molecule in mouse
RGCs, sufficiently maintains the cell survival of RGCs, but does
not promote axonal regeneration from RGCs [45], [46]. There
are many reports that RARb expression is involved in axonal
regeneration in the CNS neurons, including the spinal cord, dorsal
root ganglia [47–49] and we could show the important role of
RARb expression during optic nerve regeneration in this study.
On the other hand, the lack of regenerative capacity is attributable
in part to inhibitory factors in myelin [50]. There are a few
inhibitory environments on neonatal axonal regeneration within 2
days after birth [51]. Myelin basic protein, a marker protein of
myelin, start to express from few days after birth and inhibitory
factors from myelin inhibit axon regeneration [52]. Interestingly,
retinoic acid/its receptor, RARb counteracts myelin-dependent
inhibition of axon outgrowth by repression of Lingo-1, one of the
coreceptor of inhibitory Nogo receptor [53]. Although we do not
know the exact mechanism behind AcH3-induced RARb expres-
sion and its downstream signaling pathway, the cooperation with
histone acetyltransferase and RAR is involved in promotion of
gene expression and cell differentiation in the spinal motor neuron
development [54], [55]. Further studies are needed to elucidate
the mechanism of axon outgrowth through AcH3/RARb
expression. On the other hand, there are very few reports of
RARb expression resulting in neuroprotection or survival in
neurons [56]. To know the effects of RARb induction on
IPRG001-induced RGCs survival after nerve injury, we used
specific siRNA for RARb. In our experimental conditions, siRNA
for RARb did not affect the neuroprotective effects of IPRG001 in
rat RGCs after injury (Fig. 6). These results suggested that cell
survival effect by IPRG001 in RGCs after injury was irrelevant to
RARb expression by IPRG001. In our previous study [13],
IPRG001 supports RGC survival in vivo after optic nerve injury
through the S-nitrosylation of another target protein, Keap1,
leading to the induction of an antioxidative protein, heme
oxygenase-1. Thus RARb induction by IPRG001 seems to be
unconnected with the survival effect against RGCs after injury.
The present results in connection with our previous study [14]
strongly indicate that IPRG001 activates nNOS/NO/S-nitrosyla-
tion signaling, which leads to distinct neuroprotective and
neuritogenic actions on damaged adult rat RGCs in vivo. The
concurrent neuroprotective and neuritogenic actions of IPRG001
could provide a new therapeutic tool for CNS disorders, including
brain ischemia, age-related brain disorders, spinal cord injury, and
RGC degenerative diseases, such as glaucoma.
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